Safety and Efficacy of Low-Dose Pentavalent Antimony for Treatment of Cutaneous Leishmaniasis
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether low-dose pentavalent antimony is equally
effective when compared to the standard-dose regimen in patients with cutaneous
leishmaniasis. The study will be done in a field clinic in the state of Bahia, Brazil.